Dasatinib

PHYRAGO, SPRYCEL

Kinase Inhibitor

NADAC/unit $29.1857

No Shortage Tier 1: 113.1% PA Req: 605.5% 8 Manufacturers 48 ANDAs

Dasatinib targets specific kinase enzymes involved in cancer cell growth and proliferation.

vs. brand PHYRAGO: Generic saves up to -192% per unit

Covered Lives

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDAPOTEX INCBIOCON PHARMA LTDBRISTOL MYERS SQUIBB CODR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDHANDA THERAPEUTICS LLCLUPIN INCTEVA PHARMACEUTICALS USA INCZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Dasatinib drfinder.aiFind doctors who prescribe Dasatinib rxpbm.aiPBM spread analysis for Dasatinib clinicalrx.aiClinical profile: Dasatinib

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.